IDT expands vax manufacturing and workforce

Vaccine manufacturer IDT Biologika will expand its viral vaccine facilities in Dessau-Rosslau. In addition, the German company will hire 80 additional workers for production. The company expects this expansion will increase their output four- to five-fold. IDT Biologika release

Suggested Articles

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

On the heels of last week's deal for 120 million Pfizer-BioNTech shots, Japan has locked down 120 million more vaccines from AstraZeneca.

The pandemic price could be lowered for larger deals, CEO Stephane Bancel said. Pfizer and BioNTech priced 100M doses at $19.50 each for the U.S.